Cargando…

Chronic obstructive pulmonary disease guidelines in Europe: a look into the future

Clinical practice guidelines are ubiquitous and are developed to provide recommendations for the management of many diseases, including chronic obstructive pulmonary disease. The development of these guidelines is burdensome, demanding a significant investment of time and money. In Europe, the major...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miravitlles, Marc, Roche, Nicolas, Cardoso, João, Halpin, David, Aisanov, Zaurbek, Kankaanranta, Hannu, Kobližek, Vladimir, Śliwiński, Paweł, Bjermer, Leif, Tamm, Michael, Blasi, Francesco, Vogelmeier, Claus F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774162/ https://www.ncbi.nlm.nih.gov/pubmed/29347928 http://dx.doi.org/10.1186/s12931-018-0715-1

Ejemplares similares

A review of national guidelines for management of COPD in Europe
por: Miravitlles, Marc, et al.
Publicado: (2016)

Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients
por: Aisanov, Zaurbek, et al.
Publicado: (2020)

Russian guidelines for the management of COPD: algorithm of pharmacologic treatment
por: Aisanov, Zaurbek, et al.
Publicado: (2018)

Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019)

Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management
por: Singh, Dave, et al.
Publicado: (2016)

Erratum to: Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management
por: Singh, Dave, et al.
Publicado: (2017)

Lung Health for All: Chronic Obstructive Lung Disease and World Lung Day 2022
por: Halpin, David M. G., et al.
Publicado: (2022)

Diagnosis and Pharmacotherapy of Stable Chronic Obstructive Pulmonary Disease: The Finnish Guidelines
por: Kankaanranta, Hannu, et al.
Publicado: (2015)

Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK
por: Voorham, Jaco, et al.
Publicado: (2018)

Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries
por: Davis, Kourtney J, et al.
Publicado: (2014)

Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach
por: Stockley, Robert A, et al.
Publicado: (2013)

POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe
por: Zbozinkova, Zuzana, et al.
Publicado: (2016)

Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world
por: Aisanov, Zaurbek, et al.
Publicado: (2012)

Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation
por: Tufvesson, Ellen, et al.
Publicado: (2015)

Eosinophilic airway diseases: basic science, clinical manifestations and future challenges
por: Janson, Christer, et al.
Publicado: (2022)

Grading obstructive lung disease using tomographic pulmonary scintigraphy in patients with chronic obstructive pulmonary disease (COPD) and long-term smokers
por: Bajc, Marika, et al.
Publicado: (2014)

Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations
por: Glaab, Thomas, et al.
Publicado: (2010)

Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study
por: Koblizek, Vladimir, et al.
Publicado: (2017)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany
por: Glaab, Thomas, et al.
Publicado: (2012)

New Perspectives on Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome R, et al.
Publicado: (2022)

Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review
por: Miravitlles, Marc, et al.
Publicado: (2016)

Seinäjoki Adult Asthma Study (SAAS): a protocol for a 12-year real-life follow-up study of new-onset asthma diagnosed at adult age and treated in primary and specialised care
por: Kankaanranta, Hannu, et al.
Publicado: (2015)

Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial
por: Vogelmeier, Claus F., et al.
Publicado: (2021)

Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial
por: Bjermer, Leif H., et al.
Publicado: (2021)

Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions
por: Backer, Vibeke, et al.
Publicado: (2023)

Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency
por: Greulich, Timm, et al.
Publicado: (2018)

Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls
por: Tufvesson, Ellen, et al.
Publicado: (2020)

NuPNET looks to future nuclear physics in Europe
Publicado: (2008)

Toxoplasma gondii Genotyping: A Closer Look Into Europe
por: Fernández-Escobar, Mercedes, et al.
Publicado: (2022)

Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial
por: Kerwin, Edward M, et al.
Publicado: (2020)

Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial
por: Bjermer, Leif, et al.
Publicado: (2021)

Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement
por: Vogelmeier, Claus F, et al.
Publicado: (2021)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
por: Price, David B., et al.
Publicado: (2019)

Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review
por: Huber, Manuel B., et al.
Publicado: (2015)

Mitochondria in the Center of Human Eosinophil Apoptosis and Survival
por: Ilmarinen, Pinja, et al.
Publicado: (2014)

Regulation of Spontaneous Eosinophil Apoptosis—A Neglected Area of Importance
por: Ilmarinen, Pinja, et al.
Publicado: (2014)

Looking beyond the guidelines for perioperative antibiotics in nephrolithiasis
por: Chi, Thomas, et al.
Publicado: (2014)

Adipokines NUCB2/Nesfatin-1 and Visfatin as Novel Inflammatory Factors in Chronic Obstructive Pulmonary Disease
por: Leivo-Korpela, Sirpa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ckp7ugvs8f099t27phke1qd1c5